Apoptosis induced by DNA damage O6-methylguanine is Bcl-2 and caspase-9/3 regulated and Fas/caspase-8 independent

Cancer Research

Volumn 60, Issue 20, 2000, Pages 5815-5824

  Ochs, K ^a   Kaina, B ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

6 O METHYLGUANINE; ALKYLATING AGENT; BAG 1 PROTEIN; CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; DNA; FAS ANTIGEN; FAS LIGAND; METHYLNITRONITROSOGUANIDINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL DEATH; CHO CELL; CONTROLLED STUDY; DNA DAMAGE; DNA METHYLATION; DNA REPAIR; DNA STRAND BREAKAGE; DRUG CYTOTOXICITY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; CARRIER PROTEINS; CASPASE 3; CASPASE 8; CASPASE 9; CASPASES; CHO CELLS; CRICETINAE; CYTOCHROME C GROUP; DNA DAMAGE; ENZYME ACTIVATION; FAS LIGAND PROTEIN; GUANINE; MEMBRANE GLYCOPROTEINS; METHYLNITRONITROSOGUANIDINE; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; PHOSPHORYLATION; PROTEASE INHIBITORS; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0034667383     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Alkylating agents
2. Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients. Comparison of oral, intravenous, and hepatic intra-arterial administration
3. Clinical presentation, diagnosis, and pharmacotherapy of patients with primary brain tumors
4. Phase I and pharmacokinetic study of temozolomide on a daily-for-5-days schedule in patients with advanced solid malignancies
5. Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents
6. 6-alkylguanine and N-alkylpurines to the formation of sister chromatid exchanges, chromosomal aberrations, and gene mutations: New insights gained from studies of genetically engineered mammalian cell lines
7. 6-methylguanine-DNA methyltransferase (MGMT) cDNA in Chinese hamster cells: The role of MGMT in protection against the genotoxic effects of alkylating agents
8. 6-alkylguanine-DNA alkyltransferase
9. 6-methylguanine-DNA methyltransferase (MGMT) in transgenic mice protects against tumor initiation in two-stage skin carcinogenesis
10. 6-Methylguanine-DNA methyltransferase protects against nitrosamine-induced hepatocarcinogenesis
11. Targeted disruption of the DNA repair methyltransferase gene renders mice hypersensitive to alkylating agent
12. 6-alkylguanine
13. 6-methylguanine-DNA-methyltransferase protects Chinese hamster ovary cells from spontaneous G:C to A:T transitions
14. DNA mismatch binding defects, DNA damage tolerance, and mutator phenotypes in human colorectal carcinoma cell lines
15. 6-methylguanine in Mex-, Mex+ and methylation-tolerant mismatch repair compromised cells: Facts and models
16. Self-destruction and tolerance in resistance of mammalian cells to alkylation damage
17. Genomic instability and tolerance to alkylating agents
18. Mismatch G-T binding activity and MSH2 expression is quantitatively related to sensitivity of cells to methylating agents
19. An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair
20. Mismatch binding proteins and tolerance to alkylating agents in human cells
21. Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage
22. 6-Alkylguanine DNA lesions trigger apoptosis
23. Alkylation-induced apoptosis of embryonic stem cells in which the gene for DNA-repair, methyltransferase, had been disrupted by gene targeting
24. Role of mismatch repair and p53 in signaling induction of apoptosis by alkylating agents
25. Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: A link between the apoptosome and the proteasome pathway
26. MMT colorimetric assay for testing macrophage cytotoxicity activity in vitro
27. A novel assay for apoptosis: Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V
28. A general role for c-Fos in cellular protection against DNA-damaging carcinogens and cytostatic drugs
29. Antiapoptotic action of 1,25-dihydroxyvitamin D3 is associated with increased mitochondrial Mcl-1 and Raf-1 proteins and reduced release of cytochrome c
30. Cells deficient in DNA polymerase β are hypersensitive to alkylating agent-induced apoptosis and chromosomal breakage
31. The comet assay: Mechanisms and technical considerations
32. Bcl-xS and Bad potentiate the death suppressing activities of Bcl-xL, Bcl-2 and A1 in yeast
33. Serine phosphorylation of death antagonist Bad in response to survival factors results in binding to 14-3-3 not Bcl-xL
34. Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces Bax and promotes cell death
35. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
36. Apoptosis by death receptor
37. CD95 (Apo-1/Fas)-associating signaling proteins
38. Cross-resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases)
39. Human tumor cell strains defective in the repair of alkylation damage
40. Dependency of the yield of sister-chromatid exchanges induced by alkylating agents on fixation time. Possible involvement of secondary lesions in sister-chromatid exchange induction
41. Mismatch repair provokes chromosome aberrations in hamster cells treated with methylating agents or 6-thioguanine, but not with ethylating agents
42. A role for mismatch repair in production of chromosome aberrations by methylating agents in human cells
43. Induction of TRAIL receptor KILLER/DR5 in p53-dependent apoptosis, but not growth arrest
44. Ultraviolet-irradiation-induced apoptosis is mediated via ligand independent activation of tumor necrosis factor receptor 1
45. p53 Activates the CD95 (Apo-1/Fas) gene in response to DNA damage by anticancer drugs
46. Ordering of ceramide formation, caspase activation, and mitochondrial changes during CD95- and DNA damage-induced apoptosis
47. Mitochondrial and intracellular free-calcium regulation of radiation induced apoptosis in human leukemic cells
48. Characterization of p53 in Chinese hamster cell lines CHO-K1, CHO-WBL, and CHL: Implications for genotoxicity testing
49. Cloning and characterization of Chinese hamster p53 cDNA
50. Regulation of p53 downstream genes
51. A model for p53-induced apoptosis
52. Action of CD95 (Apo-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis
53. Involvement of the CD95 (Apo-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells
54. Bcl-xL and Bcl-2 repress a common pathway of cell death
55. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2
56. Inhibition of caspases inhibits the release of apoptotic bodies: Bcl-2 inhibits the initiation of formation of apoptotic bodies in chemotherapeutic agent-induced apoptosis
57. Taxol induces Bcl-2 phosphorylation and death of prostate cancer cells
58. Bcl-2 targets the protein kinase Raf-1 to mitochondria
59. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c
60. Apaf-1 a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3
61. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic cascade
62. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis
63. Double identity for proteins of the Bcl-2 family
64. Mitochondrial control of apoptosis: The role of cytochrome c
65. 6-methylguanine-DNA methyltransferase in human tumor and corresponding normal tissue
66. 6-methylguanine-DNA methyltransferase in relation to p53 status and therapeutic response in ovarian cancer
67. 6-methylguanine-DNA methyltransferase (MGMT) by DNA damaging agents
68. 6-methylguanine-DNA methyltransferase gene
69. 6-alkylguanine-DNA-alkyltransferase